Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine-ketamine versus propofol-ketamine versus ketamine for agitation and pain during bronchoscopy
IRCT20141001019359N18Phase 3Completed
- Sponsor
- North Khorasan University of Medical Sciences
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of ketamine, propofol and dexmedetomidine in None (3 arms), sponsored by North Khorasan University of Medical Sciences. Primary endpoints: Pain control and Sedation level. Started Nov 2025; status: completed.
02
Drugs
ketaminepropofoldexmedetomidine
Beyond the preview
Go deeper on IRCT20141001019359N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141001019359N18.